SyncAV Post-Market Trial
Research payments
$209,516
Through program year 2024, $209,516 in research payments was reported against SyncAV Post-Market Trial, across 126 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $208,066 | 111 |
| 2022 | Research | $1,450 | 15 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Timothy Smith Saint Louis, MO Named on 8 payments
- Aditya Bhonsale Pittsburgh, PA Named on 6 payments
- Gery Tomassoni Lexington, KY Named on 6 payments
- John Ip Lansing, MI Named on 5 payments
- James Strickland The Woodlands, TX Named on 5 payments
- Viral Mehta Bakersfield, CA Named on 5 payments
- Hyun Ho Jamie Kim Manchester, NH Named on 5 payments
- John Rickard Baltimore, MD Named on 5 payments
- Erich Kiehl Newport News, VA Named on 4 payments
- John Summers Oklahoma City, OK Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.